Who is sponsoring NCT03910777?

NCT03910777 is sponsored by Erzincan University.

What drugs are being tested in NCT03910777?

Interventions in NCT03910777: Early Warning Score.

What condition does NCT03910777 study?

NCT03910777 studies Early Clinical Deterioration, Early Warning Score.

Is NCT03910777 still recruiting?

NCT03910777 is currently status unknown. Last updated 17 July 2019.

Last reviewed 2019-07-17 · How we verify

NCT03910777

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Usefulness of Early Warning Systems in Detecting Early Clinical Deterioration After Intensive Care Discharge

Status unknown Last updated 17 July 2019

What this trial tests

trial testing Early Warning Score in Early Clinical Deterioration in 390 participants. Status unknown.

Timeline

1 August 2019

Primary endpoint
1 January 2020

15 January 2020

Quick facts

Lead sponsor	Erzincan University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	390
Start date	1 August 2019
Primary completion	1 January 2020
Estimated completion	15 January 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Early Warning Score

Conditions studied

Early Clinical Deterioration — all drugs for Early Clinical Deterioration →
Early Warning Score — all drugs for Early Warning Score →

Sponsor

Erzincan University

Who can join

18 and older, any sex, with Early Clinical Deterioration or Early Warning Score. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The VitalPac Early Warning Score (VIEWS) scoring system, developed by Prytherch et al., Is an early warning system that aims to predict the first 24-hour mortality in emergency patients. National early warning score (NEWS) is another early warning scoring system recommended by the Royal College of Physicians in London to detect early clinical deterioration in hospitalized patients. The aim of this study was to determine the early clinical deterioration after ICU and hence the rate of admission to intensive care and to evaluate whether these two scoring systems can be used to determine early clinical deterioration in intensive care early discharge.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Erzincan University trials

Trials by the same sponsor.

NCT07242170 — Supplementary Nerve Blocks Added to the Adductor Canal Block for Postoperative Pain Management in Primary Total Knee Art · NA · recruiting
NCT07457892 — Nicotine Dependence, Periodontal Awareness, and Clinical Periodontal Parameters in Smokers With Gingivitis and Periodont · completed
NCT07075432 — Preoperative and Postoperative Comparison of Two Nerve Blocks in Intertrochanteric Fracture Surgery · active not recruiting
NCT06510608 — Periodontal Disease and Salivary Mitofusin Levels · not yet recruiting
NCT06237387 — Association of Acne Vulgaris With Oral Hygiene and Gingivitis · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03910777 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Erzincan University
Last refreshed: 17 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03910777.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing